Live tape
Top 8, mentions 7d6,087META1,643 mentions▲ +0.06GOOGL1,179 mentions▲ +0.04NVDA788 mentions▲ +0.09TSLA529 mentions▲ +0.05MSFT528 mentions▲ +0.06AMZN494 mentions▲ +0.04SPY481 mentions▲ +0.03RBA445 mentions▲ +0.05

Equity · Healthcare

DCTH

NASDAQ

Delcath Systems, Inc.

$12.23 −1.61% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Jul 24, 2026
Price · Chart
Our own end-of-day closes 16 sessions
$14.0 $12.0 2 Jul 24 Jul

The line runs $13 on 2 July through $12.23 on 24 July, on a scale from $12.0 to $14.0. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView

The chart above plots the price of DCTH over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 16 sessions over that window: $13 on 2 July 2026 through $12.23 on 24 July 2026.

Market cap $424.4M
P/E (TTM) 1,223.0
52-week range $8.19 – $16
Avg volume 88.2K

Finazon · prior-day close, indicative (IEX-derived, not the official close) · valuation computed from SEC EDGAR filings · as of Jul 24, 2026

DCTH insider trades

SEC Form 4

DCTH has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 6 March 2026.

Date Insider Type Shares Value
06 Mar 2026 Pennell Sandra Chief Financial Officer Buy 5,533 $50K
02 Mar 2026 MICHEL GERARD J CHIEF EXECUTIVE OFFICER Buy 11,200 $100K
21 Nov 2025 Sylvester John Richard Buy 4,386 $39K
11 Nov 2025 MICHEL GERARD J CHIEF EXECUTIVE OFFICER Buy 11,500 $98K

DCTH reported financials

SEC EDGAR XBRL

DCTH reported revenue of $85.2M for the fiscal year ended 31 Dec 2025. Net income over the same period was $2.7M.

Figure Reported Period
Revenue $85.2M 31 Dec 2025 fiscal year
Net income $2.7M 31 Dec 2025 fiscal year
Diluted EPS $0.07 31 Dec 2025 fiscal year
Total assets $137.0M 30 Jun 2026 at period end
Total equity $121.1M 30 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026

DCTH earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $0.07 —
31 Mar 2026 Q1 2026 $-0.03 —
31 Dec 2025 FY 2025 $0.07 —
30 Sep 2025 Q3 2025 $0.02 —
30 Jun 2025 Q2 2025 $0.07 —
31 Mar 2025 Q1 2025 $0.03 —
31 Dec 2024 FY 2024 $-0.93 —
30 Sep 2024 Q3 2024 $0.06 —

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

DCTH institutional holders

SEC Form 13F

9 of the 45 institutional funds we track reported a DCTH position for the quarter ended 30 Jun 2026 — a combined $15.2M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Millennium Management Held (±25%) −3.7% shares 566,371 $7.1M
Marshall Wace Held (±25%) +14.3% shares 218,963 $2.8M
AQR Capital Management Added +439.0% shares 172,993 $2.2M
Man Group Added +25.7% shares 128,495 $1.6M
D. E. Shaw & Co. New position 57,894 $729K
Balyasny Asset Management Trimmed −26.1% shares 28,468 $358K
Citadel Advisors Trimmed −80.5% shares 15,043 $189K
Tudor Investment Corp Trimmed −45.3% shares 12,042 $152K
Two Sigma Investments New position 10,054 $127K
Renaissance Technologies Exited

Source: SEC EDGAR 13F filings

DCTH fails-to-deliver

SEC CNS data

On 11 Sep 2026, 696 shares of DCTH failed to deliver (about $11K).

Settlement date Shares failed Notional % of shares out
11 Sep 2026 696 $11K 0.002%
02 Sep 2026 868 $14K 0.003%
24 Aug 2026 4,481 $77K 0.013%

Source: SEC fails-to-deliver (CNS) data

Congressional trades in DCTH

STOCK Act disclosures

The most recent congressional trade disclosed in DCTH is a sale by Roger Marshall (senate, KS), dated 09 Jun 2017.

Date Member Type Amount
09 Jun 2017 filed 06 Aug 2018 Roger Marshall senate · Republican–KS Sale $1K–$15K

Source: U.S. House of Representatives financial disclosures